Transcatheter arterial microembolization (TAME) in foot and ankle pathologies: current indications and future perspectives.

Q1 Medicine
A Mazzotti, G Facchini, G D'Antonio, L Langone, F Sgubbi, G Peta, S Quarchioni, M Di Carlo, M Miceli, C Faldini
{"title":"Transcatheter arterial microembolization (TAME) in foot and ankle pathologies: current indications and future perspectives.","authors":"A Mazzotti, G Facchini, G D'Antonio, L Langone, F Sgubbi, G Peta, S Quarchioni, M Di Carlo, M Miceli, C Faldini","doi":"10.1007/s12306-026-00948-7","DOIUrl":null,"url":null,"abstract":"<p><p>Transcatheter arterial microembolization (TAME) is a minimally invasive endovascular procedure initially developed for bleeding control and later applied to the treatment of chronic musculoskeletal conditions characterized by pathological hypervascularization, to inhibit or reduce the release of inflammatory mediators. First introduced in anatomical districts such as the knee, TAME has more recently been proposed as a therapeutic option for chronic inflammatory foot and ankle disorders refractory to conservative treatment. A narrative review of the literature was conducted by searching PubMed using the keywords \"microembolization,\" \"transcatheter arterial microembolization,\" \"TAME,\" \"foot,\" and \"ankle.\" The most recent and relevant studies, including case reports, case series, and retrospective studies, were analyzed, along with the reference lists of selected articles. Clinical indications, procedural techniques, embolic materials, clinical outcomes, and complications were evaluated. The main indications for TAME in foot and ankle pathology were Achilles tendinopathy, plantar fasciopathy, and, in a single reported case, non-union of a fifth metatarsal fracture. The procedure was predominantly performed using temporary embolic agents, most commonly imipenem/cilastatin sodium. All studies reported a technical success rate of 100%, with significant pain reduction and functional improvement in most patients. Reported complications were minor and transient, with no major adverse events documented.TAME represents a promising minimally invasive therapeutic option for chronic inflammatory foot and ankle conditions refractory to conservative management, particularly Achilles tendinopathy and plantar fasciopathy. Although preliminary clinical results are encouraging, the current evidence is limited by small sample sizes and low methodological quality, underscoring the need for larger, well-designed prospective studies.</p>","PeriodicalId":18875,"journal":{"name":"MUSCULOSKELETAL SURGERY","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MUSCULOSKELETAL SURGERY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12306-026-00948-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Transcatheter arterial microembolization (TAME) is a minimally invasive endovascular procedure initially developed for bleeding control and later applied to the treatment of chronic musculoskeletal conditions characterized by pathological hypervascularization, to inhibit or reduce the release of inflammatory mediators. First introduced in anatomical districts such as the knee, TAME has more recently been proposed as a therapeutic option for chronic inflammatory foot and ankle disorders refractory to conservative treatment. A narrative review of the literature was conducted by searching PubMed using the keywords "microembolization," "transcatheter arterial microembolization," "TAME," "foot," and "ankle." The most recent and relevant studies, including case reports, case series, and retrospective studies, were analyzed, along with the reference lists of selected articles. Clinical indications, procedural techniques, embolic materials, clinical outcomes, and complications were evaluated. The main indications for TAME in foot and ankle pathology were Achilles tendinopathy, plantar fasciopathy, and, in a single reported case, non-union of a fifth metatarsal fracture. The procedure was predominantly performed using temporary embolic agents, most commonly imipenem/cilastatin sodium. All studies reported a technical success rate of 100%, with significant pain reduction and functional improvement in most patients. Reported complications were minor and transient, with no major adverse events documented.TAME represents a promising minimally invasive therapeutic option for chronic inflammatory foot and ankle conditions refractory to conservative management, particularly Achilles tendinopathy and plantar fasciopathy. Although preliminary clinical results are encouraging, the current evidence is limited by small sample sizes and low methodological quality, underscoring the need for larger, well-designed prospective studies.

经导管动脉微栓塞(TAME)治疗足部和踝关节病变:当前适应症和未来前景。
经导管动脉微栓塞(TAME)是一种微创血管内手术,最初用于控制出血,后来用于治疗以病理性血管增生为特征的慢性肌肉骨骼疾病,以抑制或减少炎症介质的释放。首次引入的解剖区域,如膝关节,TAME最近被提出作为一种治疗选择慢性炎性足和踝关节疾病难以保守治疗。通过检索PubMed检索关键词“微栓塞”、“经导管动脉微栓塞”、“TAME”、“脚”和“脚踝”,对相关文献进行叙述性回顾。分析了最新和相关的研究,包括病例报告、病例系列和回顾性研究,以及选定文章的参考文献列表。评估临床适应症、手术技术、栓塞材料、临床结果和并发症。TAME在足部和踝关节病理上的主要适应症是跟腱病、足底筋膜病,在一个报告的病例中,第五跖骨骨折不愈合。该手术主要使用临时栓塞剂,最常见的是亚胺培南/西司他汀钠。所有研究都报告了100%的技术成功率,大多数患者的疼痛明显减轻,功能得到改善。报告的并发症是轻微和短暂的,没有记录的主要不良事件。TAME是一种很有前途的微创治疗选择,用于治疗难以保守治疗的慢性炎性足部和踝关节疾病,特别是跟腱病和足底筋膜病。虽然初步临床结果令人鼓舞,但目前的证据受到样本量小和方法学质量低的限制,强调需要更大规模、设计良好的前瞻性研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MUSCULOSKELETAL SURGERY
MUSCULOSKELETAL SURGERY Medicine-Surgery
CiteScore
4.50
自引率
0.00%
发文量
35
期刊介绍: Musculoskeletal Surgery – Formerly La Chirurgia degli Organi di Movimento, founded in 1917 at the Istituto Ortopedico Rizzoli, is a peer-reviewed journal published three times a year. The journal provides up-to-date information to clinicians and scientists through the publication of original papers, reviews, case reports, and brief communications dealing with the pathogenesis and treatment of orthopaedic conditions.An electronic version is also available at http://www.springerlink.com.The journal is open for publication of supplements and for publishing abstracts of scientific meetings; conditions can be obtained from the Editors-in-Chief or the Publisher.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书